Musk says Neuralink Blindsight product is awaiting regulatory approval
Musk posted on social media that Neuralink’s Blindsight product is currently awaiting regulatory approval. The product description he cited characterizes it as a neural implant device that directly connects to the visual cortex, designed to provide visual information to the blind. The post did not specify the regulatory agency awaiting approval, the application category, or a timeline; this is not an announcement that the product has been approved or that the efficacy of restoring vision has been clinically proven.
No AI analysis yet. Tap the "AI Analysis" button above to generate one now.
Disclaimer: This content reflects the author's personal views only and does not constitute investment advice.
24H Trending
-
1
The Nikkei 225 Index fell 4.3% from its previous close, currently trading at 56,888.19.
-
2
Taiwan Weighted Index fell 5.42% from the previous close, currently trading at 36,343.37.
-
3
Samsung Electronics fell 6.09% from its previous close and is currently trading at ₩184,900.
-
4
South Korea's KOSPI index fell 4.43% from its previous close, currently trading at 4,910.24.
-
5
Shanghai Composite Index fell 1.78% from its previous close, currently trading at 3,514.00
-
6
The Hang Seng Index fell 1.86% from its previous close, currently trading at 22,417.38.
-
7
How to buy and sell KTO token? Which exchanges is KTO listed on?
-
8
According to Bloomberg, Coinbase plans to launch its own prediction market contracts in the US in the first half of 2027.
-
9
Ethereum Glamsterdam Upgrade Delayed to 2027 Due to Need to Fix Affected Smart Contracts
-
10
What is WFUSE coin? What is the future outlook for WFUSE coin?
Markets Today
Recommended Reading



